Cancer biotech Arcellx prices 8.25M-share IPO at $15
By Meghavi Singh, The Gaithersburg, MD-based Arcellx (ACLX) has priced its IPO of 8.25M shares of common stock at $15.00/share, for expected gross proceeds of ~$123.8M. The company initially filed to offer offer 8.3M shares in the range of $15 to $17 per share. In early January, the company said in a filing that it was seeking to raise up to[…]